Tibet Pharmaceuticals IncOver The Counter Market:TBET
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tibet Pharmaceuticals Inc | 10.0 | 0.0x | --- |
Aoxing Pharmaceutical Company Inc | 1.7M | -0.3x | --- |
Universe Pharmaceuticals Inc | 8.0M | -1.2x | --- |
Aida Pharmaceuticals Inc | 5.4K | 0.0x | --- |
Cumberland Pharmaceuticals Inc | 23.4M | -3.6x | --- |
Clever Leaves Holdings Inc | 7.2M | -0.3x | --- |
Company Information
Tibet Pharmaceuticals, Inc., formerly Shangri-La Tibetan Pharmaceuticals, Inc., is a specialty pharmaceutical company focusing on the research, development, manufacturing and marketing of Tibetan medicines. The Company sells both prescription and over-the-counter traditional Tibetan medicines. As of December 31, 2009, it had developed five pharmaceutical products. The Company sells its products principally to distributors in People's Republic of China, who in turn sell them to hospitals, hospital pharmacies and retail pharmacies. The Company’s products include 25 Ingredients Mandrake Pill, 28 Ingredients Pinang Pill, 18 Ingredients Chebulic (Myrobalan) Frusemide Pill, 15 Ingredients Gentiana Pill and Pomegranate Nichirin Pill.
Contact Information
- Headquarters
- Room 1701, 17/F, 90 Jaffe Road, Wanchai, Hong Kong 674400
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Hong Yu
- Chief Financial Officer
- Sabrina Ren
- Independent Director
- Solomon Chen
- Independent Director
- Wenbo Chen
- Independent Director
- Crystal Hang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $34.1M |
Shares Outstanding | 14.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.80 |
Book Value | $1.99 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | 0.0x |
Operating Margin | 31.70% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
